CAR T-Cell Benefit in Lenalidomide Refractory Myeloma ...Middle East

The CAR T-cell construct was associated with significantly better progression-free survival than standard-of-care multidrug regimens. Medscape Medical News

Hence then, the article about car t cell benefit in lenalidomide refractory myeloma was published today ( Tuesday 06/06/2023 - 08:48 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CAR T-Cell Benefit in Lenalidomide Refractory Myeloma )

Also on site :

• Germany’s Merz changes stance on Russia
• Tokyo's Yamanote Line suspended due to power outage
• Tokyo's Yamanote loop line trains out of service due to power outage